Maternal exposure to zolpidem and risk of specific birth defects
Journal of Sleep Research · 2024
DOI: 10.1111/jsr.13958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Sleep Research, 2024. Verfasst von Meredith M Howley und 11 weiteren Autor:innen. Beteiligte Einrichtung: New York State Department of Health, Birth Defects Registry, Albany, New York, USA. Hauptthemen laut MEDLINE: Maternal Exposure, Gastroschisis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCBDD CDC HHS, HSRD VA, EPA.
Abstract (Originalsprache)
Zolpidem is a non‐benzodiazepine agent indicated for treatment of insomnia. While zolpidem crosses the placenta, little is known about its safety in pregnancy. We assessed associations between self‐reported zolpidem use 1 month before pregnancy through to the end of the third month (“early pregnancy”) and specific birth defects using data from two multi‐site case–control studies: National Birth Defects Prevention Study and Slone Epidemiology Center Birth Defects Study. Analysis included 39,711 birth defect cases and 23,035 controls without a birth defect. For defects with ≥ 5 exposed cases, we used logistic regression with Firth's penalised likelihood to estimate adjusted odds ratios and 95% confidence intervals, considering age at delivery, race/ethnicity, education, body mass index, parity, early‐pregnancy antipsychotic, anxiolytic, antidepressant use, early‐pregnancy opioid use, early‐pregnancy smoking, and study as potential covariates. For defects with three–four exposed cases, we estimated crude odds ratios and 95% confidence intervals. Additionally, we explored differences in odds ratios using propensity score‐adjustment and conducted a probabilistic bias analysis of exposure misclassification. Overall, 84 (0.2%) cases and 46 (0.2%) controls reported early‐pregnancy zolpidem use. Seven defects had sufficient sample size to calculate adjusted odds ratios, which ranged from 0.76 for cleft lip to 2.18 for gastroschisis. Four defects had odds ratios > 1.8. All confidence intervals included the null. Zolpidem use was rare. We could not calculate adjusted odds ratios for most defects and estimates are imprecise. Results do not support a large increase in risk, but smaller increases in risk for certain defects cannot be ruled out.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New York State Department of Health, Birth Defects Registry, Albany, New York, USA.
- Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, New York, USA.
- CDT Analytics, Adelaide, South Australia, Australia.
- The University of Adelaide, Adelaide, South Australia, Australia.
- Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Meredith M Howley
Förderung
- NCBDD CDC HHS
- HSRD VA
- EPA
- ACL HHS
- Intramural CDC HHS
- National Center on Birth Defects and Developmental Disabilities
Zitieren
APA
Howley, M. M., Werler, M. M., Fisher, S. C., Tracy, M., Van Zutphen, A. R., Papadopoulos, E. A., Hansen, C., Ailes, E. C., Reefhuis, J., Wood, M. E., Browne, M. L., & National Birth Defects Prevention Study (2024). Maternal exposure to zolpidem and risk of specific birth defects. Journal of Sleep Research. https://doi.org/10.1111/jsr.13958
Vancouver
Howley MM, Werler MM, Fisher SC, Tracy M, Van Zutphen AR, Papadopoulos EA, et al. Maternal exposure to zolpidem and risk of specific birth defects. Journal of Sleep Research. 2024. doi:10.1111/jsr.13958
BibTeX
@article{Howley2024,
author = {Howley, Meredith M and Werler, Martha M and Fisher, Sarah C and Tracy, Melissa and Van Zutphen, Alissa R and Papadopoulos, Eleni A and Hansen, Craig and Ailes, Elizabeth C and Reefhuis, Jennita and Wood, Mollie E and Browne, Marilyn L and National Birth Defects Prevention Study, National Birth Defects Prevention Study},
title = {Maternal exposure to zolpidem and risk of specific birth defects},
journal = {Journal of Sleep Research},
year = {2024},
doi = {10.1111/jsr.13958}
}
EUVIMED